Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia

REFERENCES

• Pieters R, Kaspers GJ, Klumper E, Veerman AJ. Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art. Med Pediatr Oncol 1994;22:299–308.
   PubMedGoogle Scholar
• Kaspers GJ, Veerman AJ, Pieters R, et al. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 1997;90:2723–2729.
   PubMed Web of Science ®Google Scholar
• Kaspers GJ, Pieters R, Van Zantwijk CH, Van Wering ER, Veerman AJ. Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells. L,euk Lymphoma 1995;19:407 —416.
   Google Scholar
• Hongo T, Yajima S, Sakurai M, Horikoshi Y, Hanada R. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood 1997;89:2959–2565.
   Google Scholar
• Schmiegelow K, Nyvold C, Seyfarth J, et al. Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance. Leukemia 2001;15:1066–1071.
   PubMed Web of Science ®Google Scholar
• Grant S. Ara-C: cellular and molecular pharmacology. Adv Cancer Res 1998;72:197–233.
   PubMed Web of Science ®Google Scholar
• Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995;82:405–414.
   PubMed Web of Science ®Google Scholar
• Hannun YA. Apoptosis and the dilemma of cancer che-motherapy. Blood 1997;89:1845–1853.
   PubMed Web of Science ®Google Scholar
• Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Meth 1995; 184:39–51.
   Google Scholar
• Ormerod MG. The study of apoptotic cells by flow cytometry. Leukemia 1998;12:1013 —1025.
   Google Scholar
• Savasan S, Buck S, Wei W-Z, Ravindranath Y. Drug induced apoptosis in-vitro as a measure of drug sensitivity in acute leukemia. 3rd International Symposium on Drug Resistance in leukemia and Lymphoma, Amsterdam, The Netherlands, March 4–7, 1998. Leukemia 1998;12: 279.
   Google Scholar
• Savasan S, Buck S, Becton D, Weinstein H, Ravindranath Y. Cytotoxicity assessment by quantitating drug-induced apop-tosis and drug resistance patterns in childhood acute myeloid leukemia (AML). 41 American Society of Hematology Meeting, New Orleans, LA, December 3–7, 1999. Blood 1999;94\(suppl 1):63a.
   Google Scholar
• Willman CL, Stewart CC. General principles of multi-parameter flow cytometric analysis: applications of flow cytometry in the diagnostic pathology laboratory. Semin Diagn Pathol 1989;6:3–12.
   PubMed Web of Science ®Google Scholar
• Terstappen LW, Johnson D, Mickaels RA, et al. Multi-dimensional flow cytometric blood cell differentiation without erythrocyte lysis. Blood Cells 1991;17:585–605.
   PubMedGoogle Scholar
• Capizzi RL,, White JC, Powell BL, Perrino F. Effect of dose on the pharmacokinetic and pharmacodynamic effects of cytar-abine. Semin Hematol 1991;28(3 Suppl 4):54 — 69.
   Google Scholar
• Taub JW, Matherly LH, Stout ML, Buck SA, Gurney JG, Ravindranath Y. Enhanced metabolism of 1-beta-D-arabino-furanosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia. Blood 1996;87:3395 — 3403.
   Google Scholar
• Schorin MA, Blattner S, Gelber RD, et al. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lympho-blastic Leukemia Consortium Protocol 85-01. J Clin Oncol 1994;12:740–747.
   PubMed Web of Science ®Google Scholar
• Amylon MD, Shuster J, Pullen J, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncol-ogy Group study. Leukemia 1999;13:335— 342.
   Google Scholar
• Pullen J, Shuster JJ, Link M, et al. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia 1999;13:1696— 1707.
   Google Scholar
• Goldberg JM, Silverman LB, Levy DE, et al. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experi-ence. J Clin Oncol 2003;21:3616–3622.
   PubMed Web of Science ®Google Scholar
• Green DR, Evan GI. A matter of life and death. Cancer Cell 2002;1:19 — 30.
   PubMedGoogle Scholar
• Winter SS, Sweatman J, Shuster JJ, et al. Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study. Leukemia 2002;16:1121 — 1126.
   Google Scholar
• Niehues T, Kapaun P, Harms DO, et al. A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies. Leukemia 1999;13:614–617.
   PubMed Web of Science ®Google Scholar
• Wuchter C, Ruppert V, Schrappe M, Dorken B, Ludwig WD, Karawajew L. In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia. Blood 2002;99:4109 — 4115.
   Google Scholar